In HBV-HCC, high AURKA expression appears sufficient to drive mitotic progression despite BRCA1 presence, supporting prior reports that AURKA overexpression can override BRCA1 mediated genomic surveillance and promote cell cycle progression even under DNA damage conditions [25,45,46]. Here, AURKA is linked to hepatocellular carcinoma.